<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Monai H</submitter><pubmed_abstract>Transcranical direct current stimulation (tDCS) is a treatment known to ameliorate various neurological conditions and enhance memory and cognition in humans. tDCS has gained traction for its potential therapeutic value; however, little is known about its mechanism of action. Using a transgenic mouse expressing G-CaMP7 in astrocytes and a subpopulation of excitatory neurons, we find that tDCS induces large-amplitude astrocytic Ca(2+) surges across the entire cortex with no obvious changes in the local field potential. Moreover, sensory evoked cortical responses are enhanced after tDCS. These enhancements are dependent on the alpha-1 adrenergic receptor and are not observed in IP3R2 (inositol trisphosphate receptor type 2) knockout mice, in which astrocytic Ca(2+) surges are absent. Togethe</pubmed_abstract><journal>Nature communications</journal><pagination>11100</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4804173</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain.</pubmed_title><pmcid>PMC4804173</pmcid><pubmed_authors>Hirai H</pubmed_authors><pubmed_authors>Hirase H</pubmed_authors><pubmed_authors>Konno A</pubmed_authors><pubmed_authors>Iwai Y</pubmed_authors><pubmed_authors>Nakai J</pubmed_authors><pubmed_authors>Monai H</pubmed_authors><pubmed_authors>Oe Y</pubmed_authors><pubmed_authors>Itohara S</pubmed_authors><pubmed_authors>Ohkura M</pubmed_authors><pubmed_authors>Tanaka M</pubmed_authors><pubmed_authors>Mikoshiba K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain.</name><description>Transcranical direct current stimulation (tDCS) is a treatment known to ameliorate various neurological conditions and enhance memory and cognition in humans. tDCS has gained traction for its potential therapeutic value; however, little is known about its mechanism of action. Using a transgenic mouse expressing G-CaMP7 in astrocytes and a subpopulation of excitatory neurons, we find that tDCS induces large-amplitude astrocytic Ca(2+) surges across the entire cortex with no obvious changes in the local field potential. Moreover, sensory evoked cortical responses are enhanced after tDCS. These enhancements are dependent on the alpha-1 adrenergic receptor and are not observed in IP3R2 (inositol trisphosphate receptor type 2) knockout mice, in which astrocytic Ca(2+) surges are absent. Togethe</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2025-04-04T11:41:33.092Z</modification><creation>2019-03-27T03:10:07Z</creation></dates><accession>S-EPMC4804173</accession><cross_references><pubmed>27000523</pubmed><doi>10.1038/ncomms11100</doi></cross_references></HashMap>